Sudden cardiac death (SCD) in the young may often be the first manifestation of a genetic arrythmogenic disease that had remained undiagnosed. Despite the significant discoveries of the genetic bases of inherited arrhythmia syndromes, there remains a measurable fraction of cases where in-depth clinical and genetic investigations fail to identify the underlying SCD etiology. A few years ago, 2 cases of infants with recurrent cardiac arrest episodes, due to what appeared to be as a severe form of long QT syndrome (LQTS), came to our attention. These prompted a number of clinical and genetic research investigations that allowed us to identify a novel, closely associated to LQTS but nevertheless distinct, clinical entity that is now known as calmodulinopathy. Calmodulinopathy is a life-threatening arrhythmia syndrome, affecting mostly young individuals, caused by mutations in any of the 3 genes encoding calmodulin (CaM). Calmodulin is a ubiquitously expressed Ca2+ signaling protein that, in the heart, modulates several ion channels and participates in a plethora of cellular processes. We will hereby provide an overview of CaM's structure and function under normal and disease states, highlighting the genetic etiology of calmodulinopathy and the related disease mechanisms. We will also discuss the phenotypic spectrum of patients with calmodulinopathy and present state-of-the art approaches with patient-derived induced pluripotent stem cells that have been thus far adopted in order to accurately model calmodulinopathy in vitro, decipher disease mechanisms and identify novel therapies.

Kotta, M., Sala, L., Ghidoni, A., Badone, B., Ronchi, C., Parati, G., et al. (2018). Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young. FRONTIERS IN CARDIOVASCULAR MEDICINE, 5 [10.3389/fcvm.2018.00175].

Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young

Sala, Luca;Badone, Beatrice;Ronchi, Carlotta;Parati, Gianfranco;Zaza, Antonio;Crotti, Lia
2018

Abstract

Sudden cardiac death (SCD) in the young may often be the first manifestation of a genetic arrythmogenic disease that had remained undiagnosed. Despite the significant discoveries of the genetic bases of inherited arrhythmia syndromes, there remains a measurable fraction of cases where in-depth clinical and genetic investigations fail to identify the underlying SCD etiology. A few years ago, 2 cases of infants with recurrent cardiac arrest episodes, due to what appeared to be as a severe form of long QT syndrome (LQTS), came to our attention. These prompted a number of clinical and genetic research investigations that allowed us to identify a novel, closely associated to LQTS but nevertheless distinct, clinical entity that is now known as calmodulinopathy. Calmodulinopathy is a life-threatening arrhythmia syndrome, affecting mostly young individuals, caused by mutations in any of the 3 genes encoding calmodulin (CaM). Calmodulin is a ubiquitously expressed Ca2+ signaling protein that, in the heart, modulates several ion channels and participates in a plethora of cellular processes. We will hereby provide an overview of CaM's structure and function under normal and disease states, highlighting the genetic etiology of calmodulinopathy and the related disease mechanisms. We will also discuss the phenotypic spectrum of patients with calmodulinopathy and present state-of-the art approaches with patient-derived induced pluripotent stem cells that have been thus far adopted in order to accurately model calmodulinopathy in vitro, decipher disease mechanisms and identify novel therapies.
Articolo in rivista - Review Essay
CALM; calmodulin; catecholaminergic polymorphic ventricular tachycardia; long QT syndrome; sudden cardiac death;
CALM; calmodulin; catecholaminergic polymorphic ventricular tachycardia; long QT syndrome; sudden cardiac death
English
2018
5
175
open
Kotta, M., Sala, L., Ghidoni, A., Badone, B., Ronchi, C., Parati, G., et al. (2018). Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young. FRONTIERS IN CARDIOVASCULAR MEDICINE, 5 [10.3389/fcvm.2018.00175].
File in questo prodotto:
File Dimensione Formato  
Kotta 2018 CaM Review.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 4.83 MB
Formato Adobe PDF
4.83 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/214081
Citazioni
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 25
Social impact